| Title | Pulmonary Pharmacology and Therapeutics |
| Abbreviation | Pulm. Pharmacol. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry (medical) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2) |
| h-index | 81 |
| Overall Rank/Ranking | 6399 |
| SCImago Journal Rank (SJR) | 0.786 |
| Impact Score | 3.26 |
| Publisher | Academic Press |
| Country | United States |
| ISSN | 10945539, 15229629 |
| Best Quartile | Q2 |
| Coverage History | 1996-2023 |
Pulmonary Pharmacology and Therapeutics is a journal covering the technologies/fields/categories related to Biochemistry (medical) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2). It is published by Academic Press. The overall rank of Pulmonary Pharmacology and Therapeutics is 6399. According to SCImago Journal Rank (SJR), this journal is ranked 0.786. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 81. The best quartile for this journal is Q2.
The ISSN of Pulmonary Pharmacology and Therapeutics journal is 10945539, 15229629. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pulmonary Pharmacology and Therapeutics is cited by a total of 532 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Pulmonary Pharmacology and Therapeutics is 3.26, which is computed in 2024 as per its definition. Pulmonary Pharmacology and Therapeutics IF is increased by a factor of 0.15 and approximate percentage change is 4.82% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Pulmonary Pharmacology and Therapeutics is 3.26. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3.26 |
| 2022 | 3.11 |
| 2021 | 3.31 |
| 2020 | 3.09 |
| 2019 | 2.76 |
| 2018 | 2.79 |
| 2017 | 2.55 |
| 2016 | 2.63 |
| 2015 | 3.06 |
| 2014 | 3.34 |
Pulmonary Pharmacology and Therapeutics has an h-index of 81. It means 81 articles of this journal have more than 81 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pulmonary Pharmacology and Therapeutics is 10945539, 15229629. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pulmonary Pharmacology and Therapeutics is 6399. According to SCImago Journal Rank (SJR), this journal is ranked 0.786. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.786 |
| 2022 | 0.776 |
| 2021 | 0.671 |
| 2020 | 1.061 |
| 2019 | 0.851 |
| 2018 | 0.952 |
| 2017 | 0.860 |
| 2016 | 0.816 |
| 2015 | 1.015 |
| 2014 | 1.108 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6399 |
| 2022 | 6231 |
| 2021 | 7229 |
| 2020 | 4011 |
| 2019 | 5473 |
| 2018 | 4673 |
| 2017 | 5332 |
| 2016 | 5703 |
| 2015 | 4361 |
| 2014 | 3738 |
Pulmonary Pharmacology and Therapeutics is published by Academic Press. It's publishing house is located in United States. Coverage history of this journal is as following: 1996-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pulmonary Pharmacology and Therapeutics is Pulm. Pharmacol. Ther.. This abbreviation ('Pulm. Pharmacol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry (medical) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Pulmonary Pharmacology and Therapeutics latest impact IF is 3.26. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.34 (2014) and 2.55 (2017), respectively, in the last 10 years. Moreover, its average IS is 2.99 in the previous 10 years.
The Pulmonary Pharmacology and Therapeutics has an SJR (SCImago Journal Rank) of 0.786, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.108 in 2014 and the lowest being 0.671 in 2021. Furthermore, the average SJR of the Pulmonary Pharmacology and Therapeutics over the previous 10-year period stands at 2.99.
The latest h-index of the Pulmonary Pharmacology and Therapeutics is 81.
The Pulmonary Pharmacology and Therapeutics is published by the Academic Press, with its country of publication being the United States.
The Pulmonary Pharmacology and Therapeutics is currently ranked 6399 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3738 in 2014 and its lowest position of 7229 in 2021.
The standard ISO4 abbreviation for the Pulmonary Pharmacology and Therapeutics is Pulm. Pharmacol. Ther..
Pulmonary Pharmacology and Therapeutics is classified as a journal that the Academic Press publishes.
The Pulmonary Pharmacology and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Pulmonary Pharmacology and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 10945539, 15229629.
The best quartile for the Pulmonary Pharmacology and Therapeutics is Q2 (2023).
The Pulmonary Pharmacology and Therapeutics coverage history can be summarized as follows: 1996-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Exploration Geophysics | journal | 13768 | Taylor and Francis Ltd. | 50 | 1.06 |
| Museum Management and Curatorship | journal | 10406 | Routledge | 40 | 1.72 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| International Journal of Pest Management | journal | 13414 | Taylor and Francis Ltd. | 54 | 1.40 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 3.26 |
| 2022 | 3.11 |
| 2021 | 3.31 |
| 2020 | 3.09 |
| 2019 | 2.76 |
| 2018 | 2.79 |
| 2017 | 2.55 |
| 2016 | 2.63 |
| 2015 | 3.06 |
| 2014 | 3.34 |
